Investing Profile

Josh Bilenker

VC

Photo of Josh Bilenker, Partner at Aisling Capital
Your Intro Paths to Josh Bilenker

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →

Find Josh Bilenker on

cb
Current Investing Position
Aisling Capital Partner
Investments On Record
15
Current Fund Size
$280M

Josh Bilenker's Investments On Record (6)

CompanyStageDateRound SizeTotal Raised
ViewRay
Post-IPO EquityJul 2015$27M
Venture RoundDec 2013$30M
Venture RoundMay 2013$15M
Series CMar 2012$45M
Debt FinancingSep 2011$10M
Series CAug 2010$20M
$150M
LensAR
Private Equity RoundJan 2015$16M
Debt FinancingOct 2013$60M
Private Equity RoundOct 2013$27M
Venture RoundMar 2012$24M
$130M
Loxo Oncology
Series BMay 2014$24M
$57M
Co-investors: Dov Goldstein (Aisling Capital), David Bonita (OrbiMed), James Barrett
T2 Biosystems
Series EMar 2013$40M
Series DAug 2011$23M
$95M
Co-investors: Alan Crane (Polaris Partners), Michael Greeley (Flare Capital Partners), Harry Wilcox (Flagship Pioneering), Stacy Feld (Johnson & Johnson Innovation)
Aragon Pharmaceuticals
Series DOct 2012$50M
$80M
Co-investors: Brett Zbar (Foresite Capital), Carl Gordon (OrbiMed), Peter Svennilson (The Column Group)
Roka Bioscience
Series DJan 2012$48M
$68M
Co-investors: Jonathan Silverstein (OrbiMed Advisors), James Barrett